Citations (132)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Monika Herian & Paweł Świt. (2023) 25X-NBOMe compounds – chemistry, pharmacology and toxicology. A comprehensive review. Critical Reviews in Toxicology 53:1, pages 15-33.
Read now
Read now
Kyung Sik Yoon, Sun Mi Gu, Hye Jin Cha, Young-Hoon Kim, Jaesuk Yun & Jin-Moo Lee. (2022) 25I-NBOMe, a phenethylamine derivative, induces adverse cardiovascular effects in rodents: possible involvement of p21 (CDC42/RAC)-activated kinase 1. Drug and Chemical Toxicology 45:2, pages 898-906.
Read now
Read now
Jane Carlisle Maxwell. (2018) The Changing Face of Synthetic Cannabinoids in Texas. Journal of Psychoactive Drugs 50:4, pages 281-286.
Read now
Read now
Maren Hermanns-Clausen, Verena Angerer, Josephine Kithinji, Christina Grumann & Volker Auwärter. (2017) Bad trip due to 25I-NBOMe: a case report from the EU project SPICE II plus. Clinical Toxicology 55:8, pages 922-924.
Read now
Read now
Paul Gee, Leo J. Schep, Berit P. Jensen, Grant Moore & Stuart Barrington. (2016) Case series: toxicity from 25B-NBOMe – a cluster of N-bomb cases. Clinical Toxicology 54:2, pages 141-146.
Read now
Read now
Robert J. Tait, David Caldicott, David Mountain, Simon L. Hill & Simon Lenton. (2016) A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment. Clinical Toxicology 54:1, pages 1-13.
Read now
Read now
Benny J. Lum, Joseph J. Brophy & D. Brynn Hibbert. (2016) Identification of 4-substituted 2-(4-x-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25X-NBOMe) and analogues by gas chromatography–mass spectrometry analysis of heptafluorobutyric anhydride (HFBA) derivatives. Australian Journal of Forensic Sciences 48:1, pages 59-73.
Read now
Read now
David M. Wood, Roumen Sedefov, Andrew Cunningham & Paul I. Dargan. (2015) Prevalence of use and acute toxicity associated with the use of NBOMe drugs. Clinical Toxicology 53:2, pages 85-92.
Read now
Read now
Panagiota Nikolaou, Ioannis Papoutsis, Maria Stefanidou, Chara Spiliopoulou & Sotiris Athanaselis. (2015) 2C-I-NBOMe, an “N-bomb” that kills with “Smiles”. Toxicological and legislative aspects. Drug and Chemical Toxicology 38:1, pages 113-119.
Read now
Read now
Joji Suzuki, Justin L. Poklis & Alphonse Poklis. (2014) “My Friend Said it was Good LSD”: A Suicide Attempt Following Analytically Confirmed 25I-NBOMe Ingestion. Journal of Psychoactive Drugs 46:5, pages 379-382.
Read now
Read now
Mathias B. Forrester. (2014) NBOMe Designer Drug Exposures Reported to Texas Poison Centers. Journal of Addictive Diseases 33:3, pages 196-201.
Read now
Read now
M. H. Y. Tang, C. K. Ching, M. S. H. Tsui, F. K. C. Chu & T. W. L. Mak. (2014) Two cases of severe intoxication associated with analytically confirmed use of the novel psychoactive substances 25B-NBOMe and 25C-NBOMe. Clinical Toxicology 52:5, pages 561-565.
Read now
Read now
Articles from other publishers (120)
Daniel Martins, Eva Gil-Martins, Fernando Cagide, Catarina da Fonseca, Sofia Benfeito, Carlos Fernandes, Daniel Chavarria, Fernando Remião, Renata Silva & Fernanda Borges. (2023) Unraveling the In Vitro Toxicity Profile of Psychedelic 2C Phenethylamines and Their N-Benzylphenethylamine (NBOMe) Analogues. Pharmaceuticals 16:8, pages 1158.
Crossref
Crossref
Larissa Marcely Gomes Cassiano, Marina da Silva Oliveira, Wellington Alves de Barros, Ângelo de Fátima & Roney Santos Coimbra. (2023) Neurotoxic effects of hallucinogenic drugs 25H-NBOMe and 25H-NBOH in organotypic hippocampal cultures. Heliyon 9:7, pages e17720.
Crossref
Crossref
Laura B. Kozell, Amy J. Eshleman, Tracy L. Swanson, Shelley H. Bloom, Katherine M. Wolfrum, Jennifer L. Schmachtenberg, Randall J. Olson, Aaron Janowsky & Atheir I. Abbas. (2023)
Pharmacologic Activity of Substituted Tryptamines at 5-Hydroxytryptamine (5-HT)
2A
Receptor (5-HT
2A
R), 5-HT
2C
R, 5-HT
1A
R, and Serotonin Transporter
. Journal of Pharmacology and Experimental Therapeutics 385:1, pages 62-75.
Crossref
Crossref
Kateřina Syrová, Klára Šíchová, Hynek Danda, Eva Lhotková, Pascal Jorratt, Nikola Pinterová-Leca, Čestmír Vejmola, Lucie Olejníková-Ladislavová, Kateřina Hájková, Martin Kuchař, Jiří Horáček & Tomáš Páleníček. (2023) Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats—pharmacokinetics, effects on behaviour and thermoregulation. Frontiers in Pharmacology 14.
Crossref
Crossref
Michelle Jin Yee Neoh, Alessandro Carollo, Mengyu Lim, Ornella Corazza, Aurora Coppola & Gianluca Esposito. (2023) The novel psychoactive substances epidemic: A scientometric perspective. Addiction Neuroscience 5, pages 100060.
Crossref
Crossref
Klára Šíchová, Kateřina Syrová, Edita Kofroňová, Nikola Pinterova‐Leca, Čestmír Vejmola, Jitka Nykodemová, Petr Palivec, Lucie Olejníková, Hynek Danda, Pascal Jorratt, Šafanda Adam, Bui Quang Hiep, Kristýna Štefková‐Mazochová, Markéta Končická, Martin Kuchař & Tomáš Páleníček. (2022) Pharmacokinetics, systemic toxicity, thermoregulation and acute behavioural effects of 25CN‐NBOMe. Addiction Biology 27:5.
Crossref
Crossref
Micaela Tirri, Sabrine Bilel, Raffaella Arfè, Giorgia Corli, Beatrice Marchetti, Tatiana Bernardi, Federica Boccuto, Giovanni Serpelloni, Francesco Botrè, Fabio De-Giorgio, Krystyna Golembiowska & Matteo Marti. (2022) Effect of -NBOMe Compounds on Sensorimotor, Motor, and Prepulse Inhibition Responses in Mice in Comparison With the 2C Analogs and Lysergic Acid Diethylamide: From Preclinical Evidence to Forensic Implication in Driving Under the Influence of Drugs. Frontiers in Psychiatry 13.
Crossref
Crossref
Kyung Sik Yoon, Hye Jin Cha, Sun Ok Choi & Jin-Moo Lee. (2022) 2-((2-(4-Iodo-2,5-dimethoxyphenyl)ethylamino)methyl)phenol (25I-NBOH) and 2-(((2-(4-chloro-2,5-dimethoxyphenyl)ethyl)amino)methyl)phenol (25C-NBOH) induce adverse effects on the cardiovascular system. Toxicology Letters 355, pages 160-169.
Crossref
Crossref
Deborah Dal Farra, Alice Valdesalici, Giancarlo Zecchinato, Alfio De Sandre, Diego Saccon, Pierluigi Simonato, Ornella Corazza, Giovanni Martinotti, Andrew L. Smith & Marco Solmi. (2022) Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. International Journal of Environmental Research and Public Health 19:2, pages 915.
Crossref
Crossref
John R.H. Archer. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
131
156
.
Adam J. Potts, Simon H.L. Thomas & Simon L. Hill. 2022. Novel Psychoactive Substances. Novel Psychoactive Substances
279
300
.
Neelambika Revadigar, Ching Tary Yu & Isabelle Silverstone-Simard. 2022. Substance and Non-Substance Related Addictions. Substance and Non-Substance Related Addictions
185
194
.
Anand K. Gavai, Yamine Bouzembrak, Leonieke M. van den Bulk, Ningjing Liu, Lennert F.D. van Overbeeke, Lukas J. van den Heuvel, Hans Mol & Hans J.P. Marvin. (2021) Artificial intelligence to detect unknown stimulants from scientific literature and media reports. Food Control 130, pages 108360.
Crossref
Crossref
Deborah Rudin, Matthias E. Liechti & Dino Luethi. (2021) Molecular and clinical aspects of potential neurotoxicity induced by new psychoactive stimulants and psychedelics. Experimental Neurology 343, pages 113778.
Crossref
Crossref
Younis Abiedalla, Ahmad J. Almalki, Jack DeRuiter & C. Randall Clark. (2021) GC–MS and GC–IR analysis of methylenedioxyphenylalkylamine analogues of the psychoactive 25X-NBOMe drugs. Forensic Chemistry 23, pages 100314.
Crossref
Crossref
Laura Clancy, Morgan Philp, Ronald Shimmon & Shanlin Fu. (2020) Development and validation of a color spot test method for the presumptive detection of 25‐NBOMe compounds. Drug Testing and Analysis 13:5, pages 929-943.
Crossref
Crossref
Katarzyna Kamińska, Paweł Świt & Kamilla Malek. (2020)
2-(4-Iodo-2,5-dimethoxyphenyl)-
N
-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOME): A Harmful Hallucinogen Review
. Journal of Analytical Toxicology 44:9, pages 947-956.
Crossref
Crossref
Adelina Ion, Mirela Praisler, Catalina Mercedes Burlacu & Nicolae Catalin Stanica. (2021) Automatic identification of NBOMe illicit psychoactive substances based on combined molecular descriptors. MATEC Web of Conferences 342, pages 05008.
Crossref
Crossref
Nevriye A. YesilNevriye A. Yesil. 2021. Drogen haben kurze Beine. Drogen haben kurze Beine
71
103
.
Ahmad J. Almalki, C. Randall Clark, Younis Abiedalla & Jack DeRuiter. (2020) GC–MS analysis of methylenedioxybenzyl analogues of the serotonin receptor agonists 25X-NBOMe drugs. Forensic Chemistry 21, pages 100284.
Crossref
Crossref
Ahmad J. Almalki, C. Randall Clark, Younis Abiedalla & Jack DeRuiter. (2020) GC–MS analysis of N-(bromodimethoxybenzyl)-2-, 3-, and 4-methoxyphenethylamines: Inverse analogues of the psychoactive 25B-NBOMe drug. Forensic Chemistry 21, pages 100277.
Crossref
Crossref
Raly James Perez Custodio, Leandro Val Sayson, Chrislean Jun Botanas, Arvie Abiero, Kyung Yi You, Mikyung Kim, Hyun Jun Lee, Sung Yeun Yoo, Kun Won Lee, Yong Sup Lee, Joung‐Wook Seo, In Soo Ryu, Hee Jin Kim & Jae Hoon Cheong. (2019)
25B‐NBOMe, a novel
N
‐2‐methoxybenzyl‐phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential
. Addiction Biology 25:6.
Crossref
Crossref
Adelina Ion, Steluta Gosav, Mirela Praisler & Teodora Gosav. (2020) Machine Learning Tool Detecting NBOMe Drugs of Abuse based on Geometrical Descriptors. Machine Learning Tool Detecting NBOMe Drugs of Abuse based on Geometrical Descriptors.
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Elias Lützen, Michael Holtkamp, Imke Stamme, Robin Schmid, Michael Sperling, Michael Pütz & Uwe Karst. (2020) Multimodal imaging of hallucinogens 25C‐ and 25I‐NBOMe on blotter papers. Drug Testing and Analysis 12:4, pages 465-471.
Crossref
Crossref
Katharina Elisabeth Grafinger, Matthias E. Liechti & Evangelia Liakoni. (2019) Clinical value of analytical testing in patients presenting with new psychoactive substances intoxication. British Journal of Clinical Pharmacology 86:3, pages 429-436.
Crossref
Crossref
Ahmad J. Almalki, C. Randall Clark & Jack DeRuiter. (2020)
Structure fragmentation studies of ring‐substituted
N
‐trifluoroacetyl‐
N
‐benzylphenethylamines related to the NBOMe drugs
. Rapid Communications in Mass Spectrometry 34:4.
Crossref
Crossref
Jolanta B. Zawilska, Monika Kacela & Piotr Adamowicz. (2020) NBOMes–Highly Potent and Toxic Alternatives of LSD. Frontiers in Neuroscience 14.
Crossref
Crossref
Abu Shafi, Alex J. Berry, Harry Sumnall, David M. Wood & Derek K. Tracy. (2020) New psychoactive substances: a review and updates. Therapeutic Advances in Psychopharmacology 10, pages 204512532096719.
Crossref
Crossref
Bruna de Souza Boff, Jair Silveira Filho, Karina Nonemacher, Samilla Driessen Schroeder, Marcelo Dutra Arbo & Kéttulin Zomer Rezin. (2020) New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study. Forensic Science International 306, pages 110002.
Crossref
Crossref
Genri Kawahara, Mami S. Nakayashiki, Hideyuki Maeda, Ruri Kikura-Hanajiri, Ken-ichi Yoshida & Yukiko K. Hayashi. (2019) Antagonists for serotonin receptors ameliorate rhabdomyolysis induced by 25D-NBOMe, a psychoactive designer drug. Forensic Toxicology 38:1, pages 122-128.
Crossref
Crossref
Cristina Miliano, Matteo Marti, Nicholas Pintori, Maria Paola Castelli, Micaela Tirri, Raffaella Arfè & Maria Antonietta De Luca. (2019) Neurochemical and Behavioral Profiling in Male and Female Rats of the Psychedelic Agent 25I-NBOMe. Frontiers in Pharmacology 10.
Crossref
Crossref
Adelina Ion, Steluta Gosav & Mirela Praisler. (2019) Screening for NBOMe Hallucinogens based on Artificial Neural Networks and Structural Descriptors. Screening for NBOMe Hallucinogens based on Artificial Neural Networks and Structural Descriptors.
Michael J. Moss & Robert G. Hendrickson. (2019) Serotonin Toxicity. Journal of Clinical Psychopharmacology 39:6, pages 628-633.
Crossref
Crossref
Yoshimi Peck, Alan R. Clough, Peter N. Culshaw & Michael J. Liddell. (2019) Multi-drug cocktails: Impurities in commonly used illicit drugs seized by police in Queensland, Australia. Drug and Alcohol Dependence 201, pages 49-57.
Crossref
Crossref
Ahmad J. Almalki, C. Randall Clark & Jack DeRuiter. (2019) GC–MS analysis of regioisomeric substituted N-benzyl-4-bromo-2,5-dimethoxyphenethylamines. Forensic Chemistry 14, pages 100164.
Crossref
Crossref
Ana Maria dos Santos Moreira, Hanna Leijoto de Oliveira, João Francisco Allochio Filho, Diego Hernando Ângulo Florez, Marcela Matos Cordeiro Borges, Valdemar LacerdaJr.Jr., Wanderson Romão & Keyller Bastos Borges. (2019) NBOMe compounds: An overview about analytical methodologies aiming their determination in biological matrices. TrAC Trends in Analytical Chemistry 114, pages 260-277.
Crossref
Crossref
Kyung Sik Yoon, Jaesuk Yun, Young-Hoon Kim, Jisoon Shin, Sung Jin Kim, Jung-Wook Seo, Sung-Ae Hyun, Soo Kyung Suh & Hye Jin Cha. (2019) 2-(2,5-Dimethoxy-4-methylphenyl)-N-(2-methoxybenzyl)ethanamine (25D-NBOMe) and N-(2-methoxybenzyl)-2,5-dimethoxy-4-chlorophenethylamine (25C-NBOMe) induce adverse cardiac effects in vitro and in vivo. Toxicology Letters 304, pages 50-57.
Crossref
Crossref
Nino Cesar Marchi, Juliana Nichterwitz Scherer, Letícia Schwanck Fara, Lysa Remy, Rafaela Ornel, Monique Reis, Amanda Zamboni, Mariana Paim, Taís Regina Fiorentin, Carlos Alberto Yasin Wayhs, Lisia Von Diemen, Flavio Pechansky, Felix Henrique Paim Kessler & Renata Pereira Limberger. (2019) Clinical and Toxicological Profile of NBOMes: A Systematic Review. Psychosomatics 60:2, pages 129-138.
Crossref
Crossref
George Sam Wang & Christopher Hoyte. (2019) Novel Drugs of Abuse. Pediatrics In Review 40:2, pages 71-78.
Crossref
Crossref
Joseph J. Palamar & Monica J. Barratt. (2018) Prevalence of reagent test‐kit use and perceptions of purity among ecstasy users in an electronic dance music scene in New York City. Drug and Alcohol Review 38:1, pages 42-49.
Crossref
Crossref
Kelly Francisco da Cunha, Marcos Nogueira Eberlin, Marilyn A. Huestis & José Luiz Costa. (2018) NBOMe instability in whole blood. Forensic Toxicology 37:1, pages 82-89.
Crossref
Crossref
Huan-You Lin, Tzu-Cheng Chang & Shang-Tzen Chang. (2018) A review of antioxidant and pharmacological properties of phenolic compounds in Acacia confusa. Journal of Traditional and Complementary Medicine 8:4, pages 443-450.
Crossref
Crossref
Katharina Elisabeth Grafinger, Katja Stahl, Andreas Wilke, Stefan König & Wolfgang Weinmann. (2018)
In vitro
phase I metabolism of three phenethylamines 25D‐NBOMe, 25E‐NBOMe and 25N‐NBOMe using microsomal and microbial models
. Drug Testing and Analysis 10:10, pages 1607-1626.
Crossref
Crossref
Achim T. Caspar, Andreas B. Kollas, Hans H. Maurer & Markus R. Meyer. (2018) Development of a quantitative approach in blood plasma for low-dosed hallucinogens and opioids using LC-high resolution mass spectrometry. Talanta 176, pages 635-645.
Crossref
Crossref
J. Neugarten, B. Friedman & L. Golestaneh. 2018. Comprehensive Toxicology. Comprehensive Toxicology
304
339
.
Kelly Francisco da Cunha, Marcos Nogueira Eberlin & Jose Luiz Costa. (2017) Development and validation of a sensitive LC–MS/MS method to analyze NBOMes in dried blood spots: evaluation of long-term stability. Forensic Toxicology 36:1, pages 113-121.
Crossref
Crossref
Achim T. Caspar, Folker Westphal, Markus R. Meyer & Hans H. Maurer. (2017) LC-high resolution-MS/MS for identification of 69 metabolites of the new psychoactive substance 1-(4-ethylphenyl-)-N-[(2-methoxyphenyl)methyl] propane-2-amine (4-EA-NBOMe) in rat urine and human liver S9 incubates and comparison of its screening power with further MS techniques. Analytical and Bioanalytical Chemistry 410:3, pages 897-912.
Crossref
Crossref
Harry Sumnall. 2018. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
263
278
.
Daniel Pasin, Adam Cawley, Sergei Bidny & Shanlin Fu. (2017) Characterization of hallucinogenic phenethylamines using high-resolution mass spectrometry for non-targeted screening purposes. Drug Testing and Analysis 9:10, pages 1620-1629.
Crossref
Crossref
Barry K. Logan, Amanda L.A. Mohr, Melissa Friscia, Alex J. Krotulski, Donna M. Papsun, Sherri L. Kacinko, Jeri D. Ropero-Miller & Marilyn A. Huestis. (2017) Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013–2016: A Review. Journal of Analytical Toxicology 41:7, pages 573-610.
Crossref
Crossref
Érica Naomi Oiye, Juliana Midori Toia Katayama, Maria Fernanda Muzetti Ribeiro & Marcelo Firmino de Oliveira. (2017) Electrochemical analysis of 25H-NBOMe by Square Wave Voltammetry. Forensic Chemistry 5, pages 86-90.
Crossref
Crossref
Matthew Valento & Jacob Lebin. (2017) Emerging Drugs of Abuse: Synthetic Cannabinoids, Phenylethylamines (2C Drugs), and Synthetic Cathinones. Clinical Pediatric Emergency Medicine 18:3, pages 203-211.
Crossref
Crossref
Lorna A. Nisbet, Rafael Venson, Fiona M. Wylie & Karen S. Scott. (2017) Application of a Urine and Hair Validated LC–MS-MS Method to Determine the Effect of Hair Color on the Incorporation of 25B-NBOMe, 25C-NBOMe and 25I-NBOMe into Hair in the Rat. Journal of Analytical Toxicology 41:6, pages 559-565.
Crossref
Crossref
Genri Kawahara, Hideyuki Maeda, Ruri Kikura-Hanajiri, Ken-ichi Yoshida & Yukiko K. Hayashi. (2017) The psychoactive drug 25B-NBOMe recapitulates rhabdomyolysis in zebrafish larvae. Forensic Toxicology 35:2, pages 369-375.
Crossref
Crossref
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott & Jim McCambridge. (2017) The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendations. Public Health Research 5:4, pages 1-138.
Crossref
Crossref
N. Ihadadene, R. Janssen-Langenstein, S. Romain, F. Mazni, E. Bayle, L. Berthelon & C. Tournoud. (2017) 25I-NBOMe : hyperthermie maligne et arrêt cardiaque. Toxicologie Analytique et Clinique 29:2, pages S24.
Crossref
Crossref
Daniel Martins, Monica J. Barratt, Cristiana Vale Pires, Helena Carvalho, Mireia Ventura Vilamala, Iván Fornís Espinosa & Helena Valente. (2017) The detection and prevention of unintentional consumption of DOx and 25x-NBOMe at Portugal's Boom Festival. Human Psychopharmacology: Clinical and Experimental 32:3, pages e2608.
Crossref
Crossref
Ariane Wohlfarth, Markus Roman, Mikael Andersson, Fredrik C. Kugelberg, Xingxing Diao, Jeremy Carlier, Caroline Eriksson, Xiongyu Wu, Peter Konradsson, Martin Josefsson, Marilyn A. Huestis & Robert Kronstrand. (2017)
25C-NBOMe and 25I-NBOMe metabolite studies in human hepatocytes,
in vivo
mouse and human urine with high-resolution mass spectrometry
. Drug Testing and Analysis 9:5, pages 680-698.
Crossref
Crossref
Stephen L. Thornton, Sarah Hoehn & Roy R. Gerona. (2017) Seizures, Systemic Inflammatory Response, and Rhabdomyolysis Associated With Laboratory-Confirmed 2C-I and 25-I Exposure. Pediatric Emergency Care, pages 1.
Crossref
Crossref
Loretta T Ford & Jonathan D Berg. (2016) Analysis of legal high materials by ultra-performance liquid chromatography with time of flight mass spectrometry as part of a toxicology vigilance system: what are the most popular novel psychoactive substances in the UK?. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 54:2, pages 219-229.
Crossref
Crossref
Ana Flávia B. AndradeSamuel Kasahun MamoJose Gonzalez-Rodriguez. (2017) Rapid Screening Method for New Psychoactive Substances of Forensic Interest: Electrochemistry and Analytical Determination of Phenethylamines Derivatives (NBOMe) via Cyclic and Differential Pulse Voltammetry. Analytical Chemistry 89:3, pages 1445-1452.
Crossref
Crossref
Camille Richeval, Alexandra Boucher, Luc Humbert, Mélodie Phanithavong, Jean-François Wiart, Mustapha Moulsma, Antony Citterio-Quentin, Thierry Coulon, Romain Hernu, Thierry Vial, Delphine Allorge & Jean-Michel Gaulier. (2017) Retrospective identification of 25I-NBOMe metabolites in an intoxication case. Toxicologie Analytique et Clinique 29:1, pages 71-81.
Crossref
Crossref
Sandra Bodeau, Youssef Bennis, Océane Régnaut, Nicolas Fabresse, Camille Richeval, Luc Humbert, Jean-Claude Alvarez, Delphine Allorge & Anne-Sophie Lemaire-Hurtel. (2017) LSD instead of 25I-NBOMe: The revival of LSD? A case report. Toxicologie Analytique et Clinique 29:1, pages 139-143.
Crossref
Crossref
Achim T. Caspar, Simon D. Brandt, Andreas E. Stoever, Markus R. Meyer & Hans H. Maurer. (2017) Metabolic fate and detectability of the new psychoactive substances 2-(4-bromo-2,5-dimethoxyphenyl)- N- [(2-methoxyphenyl)methyl]ethanamine (25B-NBOMe) and 2-(4-chloro-2,5-dimethoxyphenyl)- N- [(2-methoxyphenyl)methyl]ethanamine (25C-NBOMe) in human and rat urine by GC–MS, LC–MS n , and LC–HR–MS/MS approaches. Journal of Pharmaceutical and Biomedical Analysis 134, pages 158-169.
Crossref
Crossref
Marek Wiergowski, Justyna Aszyk, Michał Kaliszan, Kamila Wilczewska, Jacek Sein Anand, Agata Kot-Wasik & Zbigniew Jankowski. (2017) Identification of novel psychoactive substances 25B-NBOMe and 4-CMC in biological material using HPLC-Q-TOF-MS and their quantification in blood using UPLC–MS/MS in case of severe intoxications. Journal of Chromatography B 1041-1042, pages 1-10.
Crossref
Crossref
Christine Murphy & George Sam Wang. 2017. Case Studies in Medical Toxicology. Case Studies in Medical Toxicology
79
88
.
Adam L. Halberstadt. 2017. Neuropharmacology of New Psychoactive Substances (NPS). Neuropharmacology of New Psychoactive Substances (NPS)
283
311
.
Carlos Alberto Yasin Wayhs, Monique dos Reis, Kristiane de Cássia Mariotti, Wanderson Romão, Boniek Gontijo Vaz, Rafael Scorsatto Ortiz & Renata Pereira Limberger. (2016) NBOMe: perfil de apreensões da Polícia Federal no Brasil. Revista Brasileira de Criminalística 5:3, pages 22-29.
Crossref
Crossref
Sabra Botch-Jones, Jamie Foss, David Barajas, Frank Kero, Craig Young & Jason Weisenseel. (2016) The detection of NBOMe designer drugs on blotter paper by high resolution time-of-flight mass spectrometry (TOFMS) with and without chromatography. Forensic Science International 267, pages 89-95.
Crossref
Crossref
Mounir Ouzir & Mohammed Errami. (2016) Etiological theories of addiction: A comprehensive update on neurobiological, genetic and behavioural vulnerability. Pharmacology Biochemistry and Behavior 148, pages 59-68.
Crossref
Crossref
Theresa M. Carbonaro & Michael B. Gatch. (2016) Neuropharmacology of N,N-dimethyltryptamine. Brain Research Bulletin 126, pages 74-88.
Crossref
Crossref
Folker Westphal, Ulrich Girreser & Delia Waldmüller. (2016)
Analytical characterization of four new
ortho
-methoxybenzylated amphetamine-type designer drugs
. Drug Testing and Analysis 8:9, pages 910-919.
Crossref
Crossref
Boris Duffau, Cristian Camargo, Marcelo Kogan, Edwar Fuentes & Bruce Kennedy Cassels. (2016) Analysis of 25 C NBOMe in Seized Blotters by HPTLC and GC–MS. Journal of Chromatographic Science 54:7, pages 1153-1158.
Crossref
Crossref
Samantha J. Coward & Hilary J. Hamnett. 2016. Forensic Toxicology: Drug Use and Misuse. Forensic Toxicology: Drug Use and Misuse
127
146
.
Ruben Thanacoody. (2016) Serotonin syndrome. Medicine 44:2, pages 95-96.
Crossref
Crossref
Sebastian Leth-Petersen, Charlotte Gabel-Jensen, Nic Gillings, Szabolzs Lehel, Hanne D. Hansen, Gitte M. Knudsen & Jesper L. Kristensen. (2015) Metabolic Fate of Hallucinogenic NBOMes. Chemical Research in Toxicology 29:1, pages 96-100.
Crossref
Crossref
Adam Cawley, Daniel Pasin, Namuun Ganbat, Laura Ennis, Corrine Smart, Candace Greer, John Keledjian, Shanlin Fu & Alex Chen. (2016) The potential for complementary targeted/non-targeted screening of novel psychoactive substances in equine urine using liquid chromatography-high resolution accurate mass spectrometry. Analytical Methods 8:8, pages 1789-1797.
Crossref
Crossref
Dariusz Zuba, Piotr Adamowicz & Simon Elliott. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
935
944
.
Evan S. Herrmann, Patrick S. Johnson, Matthew W. Johnson & Ryan Vandrey. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
893
902
.
Marcelo Dutra Arbo, Rachel Picada Bulcão, Luciana Grazziotin Rossato, Elza Callegari, Lucas Henrique Cendron, Eduardo Rodrigues Cabrera, Marco Antonio de Freitas & Mirna Bainy Leal. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse
50
60
.
Harry Sumnall. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
21
.
H. R. Sumnall. 2016. Handbuch Psychoaktive Substanzen. Handbuch Psychoaktive Substanzen
1
19
.
Michael F Weaver, John A Hopper & Erik W Gunderson. (2015) Designer drugs 2015: assessment and management. Addiction Science & Clinical Practice 10:1.
Crossref
Crossref
Anna Rickli, Dino Luethi, Julian Reinisch, Danièle Buchy, Marius C. Hoener & Matthias E. Liechti. (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99, pages 546-553.
Crossref
Crossref
Jolanta B. Zawilska & Dariusz Andrzejczak. (2015) Next generation of novel psychoactive substances on the horizon – A complex problem to face. Drug and Alcohol Dependence 157, pages 1-17.
Crossref
Crossref
M.A. Hieger, S.R. Rose, K.L. Cumpston, P.E. Stromberg, S. Miller & B.K. Wills. (2015) Severe poisoning after self-reported use of 2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, a novel substituted amphetamine: a case series. The American Journal of Emergency Medicine 33:12, pages 1843.e1-1843.e3.
Crossref
Crossref
Lyndsey M. Lowe, Brianna L. Peterson & Fiona J. Couper. (2015) A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State. Journal of Analytical Toxicology 39:8, pages 668-671.
Crossref
Crossref
Justin L. Poklis, Sara K. Dempsey, Kai Liu, Joseph K. Ritter, Carl Wolf, Shijun Zhang & Alphonse Poklis. (2015) Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication. Journal of Analytical Toxicology 39:8, pages 607-616.
Crossref
Crossref
Justin L. Poklis, Stephen A. Raso, Kylie N. Alford, Alphonse Poklis & Michelle R. Peace. (2015)
Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-
N
-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper
. Journal of Analytical Toxicology 39:8, pages 617-623.
Crossref
Crossref
Kevin G. Shanks, Thomas Sozio & George S. Behonick. (2015) Fatal Intoxications with 25B-NBOMe and 25I-NBOMe in Indiana During 2014. Journal of Analytical Toxicology 39:8, pages 602-606.
Crossref
Crossref
Kathleen S Bonnici, Paul I Dargan & David M Wood. (2015) Novel psychoactive substances or ‘legal highs'. British Journal of Hospital Medicine 76:9, pages C130-C134.
Crossref
Crossref
Gaël Le Roux, Chloé Bruneau, Bénédicte Lelièvre, Marie Bretaudeau Deguigne, Alain Turcant, Patrick Harry & David Boels. (2015) Recreational phenethylamine poisonings reported to a French poison control center. Drug and Alcohol Dependence 154, pages 46-53.
Crossref
Crossref
José Coelho Neto. (2015) Rapid detection of NBOME's and other NPS on blotter papers by direct ATR-FTIR spectrometry. Forensic Science International 252, pages 87-92.
Crossref
Crossref
Ken-ichi Yoshida, Kanju Saka, Kaori Shintani-Ishida, Hideyuki Maeda, Makoto Nakajima, Shu-ichi Hara, Masahide Ueno, Katsunori Sasaki, Hirotaro Iwase & Tetsuya Sakamoto. (2015) A case of fatal intoxication due to the new designer drug 25B-NBOMe. Forensic Toxicology 33:2, pages 396-401.
Crossref
Crossref
Mette Findal Andreasen, Rasmus Telving, Ingrid Rosendal, Marlene Beyer Eg, Jørgen Bo Hasselstrøm & Ljubica Vukelic Andersen. (2015) A fatal poisoning involving 25C-NBOMe. Forensic Science International 251, pages e1-e8.
Crossref
Crossref
David Baumeister, Luis M. Tojo & Derek K. Tracy. (2015) Legal highs: staying on top of the flood of novel psychoactive substances. Therapeutic Advances in Psychopharmacology 5:2, pages 97-132.
Crossref
Crossref
Victoria B. Kueppers & Clive T. Cooke. (2015) 25I-NBOMe related death in Australia: A case report. Forensic Science International 249, pages e15-e18.
Crossref
Crossref
Oscar D'Agnone. (2015) What have we learned and what can we do about NPS?. Drugs and Alcohol Today 15:1, pages 28-37.
Crossref
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) New Synthetic Drugs in Addictovigilance. Therapies 70:2, pages 179-189.
Crossref
Crossref
François Chavant, Alexandra Boucher, Reynald Le Boisselier, Sylvie Deheul & Danièle Debruyne. (2015) Nouvelles drogues de synthèse en addictovigilance. Therapies 70:2, pages 167-178.
Crossref
Crossref
Joji Suzuki, Michael A. Dekker, Erin S. Valenti, Fabiola A. Arbelo Cruz, Ady M. Correa, Justin L. Poklis & Alphonse Poklis. (2015) Toxicities Associated With NBOMe Ingestion—A Novel Class of Potent Hallucinogens: A Review of the Literature. Psychosomatics 56:2, pages 129-139.
Crossref
Crossref
Patil Armenian & Roy R. Gerona. (2014) The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man. The American Journal of Emergency Medicine 32:11, pages 1444.e3-1444.e5.
Crossref
Crossref
Sebastian Leth-Petersen, Christoffer Bundgaard, Martin Hansen, Martin A. Carnerup, Jan Kehler & Jesper Langgaard Kristensen. (2014) Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability. Neurochemical Research 39:10, pages 2018-2023.
Crossref
Crossref
Will Lawn, Monica Barratt, Martin Williams, Abi Horne & Adam Winstock. (2014) The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample. Journal of Psychopharmacology 28:8, pages 780-788.
Crossref
Crossref
YC Chan, ML Tse & FL Lau. (2017) Hong Kong Poison Information Centre: Annual Report 2013. Hong Kong Journal of Emergency Medicine 21:4, pages 249-259.
Crossref
Crossref
Esther Papaseit, Magí Farré, Fabrizio Schifano & Marta Torrens. (2014) Emerging drugs in Europe. Current Opinion in Psychiatry 27:4, pages 243-250.
Crossref
Crossref
Megan E. Musselman & Jeremy P. Hampton. (2014)
“
Not for Human Consumption”: A Review of Emerging Designer Drugs
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:7, pages 745-757.
Crossref
Crossref
D. M. Wood, S. L. Hill, S. H. L. Thomas & P. I. Dargan. (2014) Using poisons information service data to assess the acute harms associated with novel psychoactive substances. Drug Testing and Analysis 6:7-8, pages 850-860.
Crossref
Crossref
L. A. King. (2013) New phenethylamines in Europe. Drug Testing and Analysis 6:7-8, pages 808-818.
Crossref
Crossref
Justin L. Poklis, Carol R. Nanco, Michelle M. Troendle, Carl E. Wolf & Alphonse Poklis. (2013) Determination of 4‐bromo‐2,5‐dimethoxy‐N‐[(2‐methoxyphenyl)methyl]‐benzeneethanamine (25B‐NBOMe) in serum and urine by high performance liquid chromatography with tandem mass spectrometry in a case of severe intoxication. Drug Testing and Analysis 6:7-8, pages 764-769.
Crossref
Crossref
Randy L. Luciano & Mark A. Perazella. (2014) Nephrotoxic effects of designer drugs: synthetic is not better!. Nature Reviews Nephrology 10:6, pages 314-324.
Crossref
Crossref
S. Grautoff & J. Kähler. (2014) Lebensgefährliche Intoxikation mit der neuen psychoaktiven Substanz 25C-NBOMeNear fatal intoxication with the novel psychoactive substance 25C-NBOMe. Medizinische Klinik - Intensivmedizin und Notfallmedizin 109:4, pages 271-275.
Crossref
Crossref
J. L. Poklis, D. J. Clay & A. Poklis. (2014) High-Performance Liquid Chromatography with Tandem Mass Spectrometry for the Determination of Nine Hallucinogenic 25-NBOMe Designer Drugs in Urine Specimens. Journal of Analytical Toxicology 38:3, pages 113-121.
Crossref
Crossref
Adam L. Halberstadt & Mark A. Geyer. (2014) Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology 77, pages 200-207.
Crossref
Crossref
Francesco Saverio Bersani, Ornella Corazza, Gabriella Albano, Giuseppe Valeriani, Rita Santacroce, Flaminia Bolzan Mariotti Posocco, Eduardo Cinosi, Pierluigi Simonato, Giovanni Martinotti, Giuseppe Bersani & Fabrizio Schifano. (2014) 25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug. BioMed Research International 2014, pages 1-6.
Crossref
Crossref
Justin L. Poklis, Kelly G. Devers, Elise F. Arbefeville, Julia M. Pearson, Eric Houston & Alphonse Poklis. (2014) Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death. Forensic Science International 234, pages e14-e20.
Crossref
Crossref
J.M. Marraffa. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
248
251
.
Robert Haberzettl, Bettina Bert, Heidrun Fink & Meredith A. Fox. (2013) Animal models of the serotonin syndrome: A systematic review. Behavioural Brain Research 256, pages 328-345.
Crossref
Crossref
David G E CaldicottStephen J BrightMonica J Barratt. (2013) NBOMe — a very different kettle of fish …. Medical Journal of Australia 199:5, pages 322-323.
Crossref
Crossref